Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Taiwan J Obstet Gynecol ; 62(2): 252-255, 2023 Mar.
Article in English | MEDLINE | ID: mdl-36965891

ABSTRACT

OBJECTIVE: Pericervical ring reconstruction through restoration of pubocervical and rectovaginal fascia is performed concomitantly with sacrospinous hysteropexy as a transvaginal native tissue procedure for vaginal apical prolapse. The main goal of this study was to assess subjective and objective outcomes of sacrospinous hysteropexy and additional pericervical ring reconstruction. MATERIALS AND METHODS: We conducted a prospective and observational study. All participants underwent sacrospinous hysteropexy and pericervical ring reconstruction and perineorrhaphy. Surgical complications, anatomical and functional efficacy were assessed. RESULTS: 108 cases were included in this study. The mean follow-up timeframe was 18.62 ± 1.22 months (minimum 12 and maximum 26 months). All parameters of subjective outcomes were improved significantly. The overall anatomic success rate was 92.59%. Mean operation time was 50.64 ± 20.8 min. No major intraoperative or postoperative complications were found. There was no statistically significant difference in demographic characteristics including age, BMI, gravidity, medical comorbidities, menopausal status, sexual activity, pretreatment prolapse severity scores between subjects with failure, and good anatomical outcome. Recurrence was mostly observed in patients with higher prolapse stages of anterior and apical compartments. Baseline POP-Q parameters Ba, C, D were significantly higher in cases with failure. CONCLUSION: Our study disclosed sustainable anatomic and subjective outcomes of modified sacrospinous hysteropexy by means of additional pericervical ring reconstruction.


Subject(s)
Pelvic Organ Prolapse , Uterine Prolapse , Female , Humans , Prospective Studies , Treatment Outcome , Uterus/surgery , Uterine Prolapse/surgery , Vagina/surgery , Pelvic Organ Prolapse/surgery , Gynecologic Surgical Procedures/methods
2.
J Med Life ; 14(2): 250-256, 2021.
Article in English | MEDLINE | ID: mdl-34104249

ABSTRACT

This was a clinical trial study that aimed to investigate the efficacy of vaginal chlorhexidine gel in the treatment of vulvovaginal candidiasis, bacterial vaginosis, and nonspecific vaginitis. The study population included patients who complained of vaginal discharge and presented to our University Gynecology Clinic. The data were analyzed using the Statistical Package for the Social Sciences (SPSS) software. The student t-test and Mann-Whitney U test were used to analyze the quantitative and ordinal data, respectively. In order to analyze the qualitative data, the Chi-square or Fischer's exact tests were used. The mean satisfaction score in the vulvovaginal candidiasis patients who received chlorhexiine vaginal gel was 9.06 and 8.29 in the patients who received clotrimazole vaginal cream. The Mann-Whitney test did not show a statistically significant difference between mean scores of VAS in these two groups with vulvovaginal candidiasis (P=0.027). Among the patients with bacterial vaginosis, the mean satisfaction score was 8.91 in the chlorhexidine vaginal gel group and 8.72 in the metronidazole tablet group (P=0.607). In the nonspecific vaginitis group, the mean satisfaction score was 8.83 in the chlorhexidine vaginal gel group and 9.17 in the combination group (metronidazole + clotrimazole vaginal cream)(P=0.401). The highest mean visual analog scale score (VAS) score was documented in the combination therapy group. We found that chlorhexidine vaginal gel is a more effective method for the treatment and improvement of vaginal infections. The benefits of chlorhexidine gel have a positive therapeutic effect as a single drug in nonspecific vaginitis, rather than simultaneous administration of two agents.


Subject(s)
Candidiasis, Vulvovaginal/drug therapy , Chlorhexidine/therapeutic use , Clotrimazole/therapeutic use , Metronidazole/therapeutic use , Vaginosis, Bacterial/drug therapy , Vulvovaginitis/drug therapy , Adult , Clotrimazole/administration & dosage , Drug Therapy, Combination , Female , Humans , Metronidazole/administration & dosage , Patient Satisfaction , Visual Analog Scale
3.
J Family Reprod Health ; 15(4): 252-257, 2021 Dec.
Article in English | MEDLINE | ID: mdl-35340795

ABSTRACT

Objective: This study aimed to compare women's body image, sexual function and satisfaction before and after gynecologic cosmetic surgery. The study also aimed to assess women husband's sexual satisfaction. Materials and methods: This was a pretest-posttest study. A sample of 50 women attending the pelvic floor clinic of Tehran University of Medical Sciences for gynecologic cosmetic surgery was entered into the study. Surgeries included labiaplasty, clitoral hoodectomy, vaginoplasty, vaginal rejuvenation, anterior and posterior colporrhaphy, perineoplasty, and perineorrhaphy. Women were assessed for the Body Image Quality of Life Inventory (BIQLI), the Larson Sexual Satisfaction Questionnaire (LSSQ-F), and Female Sexual Function Inventory (FSFI-6) at two points in time: baseline (one week before surgery) and 3 months after surgery. Similarly, the male partners were assed for sexual satisfaction using the Larson Sexual Satisfaction Questionnaire (LSSQ-M). To analyze the data paired samples t-test was applied. Results: The mean (SD) age of women was 43.36 (8.6) years and the mean (SD) duration of marriage was 22.18 (9.7) years. Ninety-four percent had history of vaginal delivery and 58.7 percent attend surgery due to husband's sexual dissatisfaction. The results showed that women's body image, sexual function and couples' sexual satisfaction improved significantly after gynecologic cosmetic surgery (p ≤ 0.001). Conclusion: The findings suggest that female genital cosmetic surgery improved the body image and sexual function of women and sexual satisfaction in couples that might lead to a more pleasurable and healthier marital relationship.

4.
J Obstet Gynaecol ; 37(2): 223-227, 2017 Feb.
Article in English | MEDLINE | ID: mdl-27750486

ABSTRACT

The aim of this study was to investigate the role of serum Interleukin-6 (IL-6) as a predictive value to make decision for surgical interventions when ovarian torsion (OT) is suspected. This study was performed on 284 women with lower abdominal pain. IL-6 levels were compared between OT (n = 67, 23.6%) and control groups (n = 217, 76.4%). For the purpose of diagnosis of OT, sensitivity and specificity of IL-6 at the cut-off point of 9.6 pg/ml were 41.79 and 82.49%, respectively. Patients with ovarian masses on ultrasound and IL-6 >9.6 pg/ml were found to be 24 times more likely to develop OT. Patients with serum IL-6 >9.6 pg/ml who lacked blood flow in ovarian Doppler ultrasound had 40.75 times higher risk of developing OT. It seems that simultaneous use of Doppler ultrasound and serum IL-6 levels can be helpful for early diagnosis of OT and making decision for surgical intervention.


Subject(s)
Abdominal Pain/blood , Interleukin-6/blood , Ovarian Diseases/blood , Ovary/pathology , Torsion Abnormality/blood , Abdominal Pain/diagnosis , Abdominal Pain/etiology , Adolescent , Adult , Biomarkers/blood , Case-Control Studies , Female , Humans , Ovarian Diseases/diagnosis , Ovary/diagnostic imaging , ROC Curve , Sensitivity and Specificity , Torsion Abnormality/diagnosis , Ultrasonography, Doppler , Young Adult
6.
J Family Reprod Health ; 7(3): 109-13, 2013 Sep.
Article in English | MEDLINE | ID: mdl-24971112

ABSTRACT

OBJECTIVE: To compare side effects between users of two kinds of injectable contraceptives (Depo-medroxy progesterone acetate and Cyclofem). MATERIALS AND METHODS: This cross-sectional descriptive study included 250 women, aged 18-40 years, using Depo-medroxy progesterone acetate (DMPA) or Cyclofem. The volunteers were examined six months after using contraceptive, and they were asked about following symptoms: weight changes, irregular bleeding, dysparounia, vaginal dryness, headache, breast pain, bone pain, and discontinuation reason. The data were analyzed by statistical methods. RESULTS: THE IMPORTANT SIDE EFFECTS OF DMPA WERE: irregular bleeding (93.60%), weight gain (48%), bone pain (24%) and vaginal dryness (10.40%), while the side effects in the Cyclofem group were: irregular bleeding (65.60%), headache (14.4%) and breast sensitivity (20%). Bleeding pattern changes were the most important problem leading to discontinuation of both contraceptive methods in our participants. CONCLUSION: The results of the study showed that the most important problem in both groups was change in bleeding pattern. Proper consulting by a trained expert reduces the high amount of discontinuation and their failure rates.

7.
ISRN Obstet Gynecol ; 2012: 802648, 2012.
Article in English | MEDLINE | ID: mdl-22685671

ABSTRACT

Objective. The aim of the study was to determine the prevalence of vaginal flatus and some related risk factors in Iranian women. Methods. After conducting a pilot study, a sample size of 1000 subjects of 18 to 80 years was determined; of those 58 were unable to cooperate for various reasons. Age, parity, marital status, birth history, body mass index, and the weight of the largest newborn were collected. After a full gynecologic examination looking for pelvic organ prolapse, patients were asked about vaginal flatus and the frequency and time of occurrence. The results were studied using the chi-square test and independent t-test considering an alpha error of less than 0.05. Results. The prevalence of vaginal flatus was mainly 20% in this study, but embarrassment was observed in 5.7% of these women. 4% in the group were with no history of sexual contact (virgin). Vaginal flatus mostly started after vaginal delivery (45%) or spontaneously (34%); however, it was also reported after cesarean section and other pelvic operations. The most common activity leading to vaginal flatus was intercourse (54%); however, the time which had resulted in more inconvenience for the patients was during physical activities (92%). BMI and age were significantly lower in the patients (P < 0.0001). The grade of prolapse was lower in the patients (P < 0.0001). Conclusion. Low age, low body mass index, and vaginal delivery can affect the incidence of a noisy vagina.

8.
Int J Gynaecol Obstet ; 118(1): 4-6, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22541809

ABSTRACT

OBJECTIVE: To compare maternal and neonatal outcomes associated with the "push" and "pull" methods for impacted fetal head extraction during cesarean delivery. METHODS: A prospective study was conducted at Imam Reza Hospital, Kermanshah, Iran, from April 2006 to March 2008. After failed vacuum extraction, women with obstructed labor caused by impacted fetal head were randomly assigned to deliver via the push method (n=35) or the pull method (n=37). The outcomes investigated included operation time, operative blood loss, incidence of extension of the uterine incision, and postpartum fever. Data were analyzed using χ(2) and Student t tests. RESULTS: Mean operative time and incidence of extension of the uterine incision were significantly increased in the group that delivered via the push method (P<0.001). There were no significant differences in the other maternal and neonatal morbidities between the groups, although there was 1 case of neonatal femoral fracture in the pull group. CONCLUSION: Although the pull method may lead to some neonatal complications, it is associated with lower maternal morbidity than the push method when used for impacted fetal head extraction during cesarean delivery.


Subject(s)
Cesarean Section/methods , Dystocia , Obstetric Labor Complications , Pregnancy Outcome , Adult , Female , Fever/epidemiology , Head , Humans , Infant, Newborn , Iran , Postpartum Period , Pregnancy , Prospective Studies , Vacuum Extraction, Obstetrical/methods , Young Adult
9.
Int J Gynaecol Obstet ; 117(1): 78-80, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22261129

ABSTRACT

OBJECTIVE: To compare 2 different methods-multiple doses of misoprostol and a combination of misoprostol and oxytocin-for termination of pregnancy in the second trimester. METHODS: Between 2006 and 2008, 120 women undergoing termination of second-trimester pregnancy in 2 hospitals in Kermanshah, Iran, were enrolled in a randomized trial comparing 2 treatments. In each treatment group, an initial vaginal dose of 600 µg of misoprostol was placed in the posterior fornix. After 6 hours, an intravenous infusion of concentrated oxytocin was given to women in group A, and 400 µg of vaginal misoprostol was given every 6 hours to women group B, up to a maximum of 4 doses. The outcomes were compared via χ(2) and independent t tests. RESULTS: Within 30 hours, 96.7% of women in group A and 96.7% of women in group B delivered successfully. The average duration between induction and delivery time was 12.3±6.0 hours in group A and 12.1±6.0 hours in group B (P>0.05). CONCLUSION: The use of misoprostol with oxytocin, and multiple doses of misoprostol gave similar results for termination of pregnancy in the second trimester.


Subject(s)
Abortifacient Agents, Nonsteroidal/administration & dosage , Abortion, Induced/methods , Misoprostol/administration & dosage , Oxytocics/administration & dosage , Oxytocin/administration & dosage , Abortifacient Agents, Nonsteroidal/adverse effects , Abortion, Induced/adverse effects , Administration, Intravaginal , Adult , Drug Therapy, Combination , Female , Humans , Infusions, Intravenous , Iran , Misoprostol/adverse effects , Oxytocics/adverse effects , Oxytocin/adverse effects , Pregnancy , Pregnancy Trimester, Second , Single-Blind Method , Time Factors , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL